Terug
Dagbereik
€ 122,99
€ 126,34
52-Weeksbereik
€ 103,23
€ 164,28
Volume
357.751
50D / 200D Gem.
€ 131,85
/
€ 134,94
Vorige Slotkoers
€ 121,06
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 20,7 | 0,4 |
| P/B | 3,1 | 2,9 |
| ROE % | 15,3 | 3,8 |
| Net Margin % | 10,4 | 3,9 |
| Rev Growth 5Y % | 4,0 | 10,0 |
| D/E | 0,6 | 0,2 |
Koersdoel Analisten
Hold
€ 169,67
+36.7%
Low: € 133,00
High: € 220,00
Forward K/W
22,2
Forward WPA
€ 5,59
WPA Groei (sch.)
+0,0%
Omzet Sch.
3,9 B
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 7,23
€ 6,90 – € 7,55
|
4,4 B | 2 |
| FY2027 |
€ 6,49
€ 5,92 – € 6,92
|
4,1 B | 6 |
| FY2026 |
€ 5,59
€ 5,40 – € 5,68
|
3,9 B | 6 |
Belangrijkste Punten
Revenue grew 4,01% annually over 5 years — modest growth
ROE of 15,28% — decent returns on equity
Generating 299,58M in free cash flow
Capital efficient — spends only 7,16% of revenue on capex
Groei
Revenue Growth (5Y)
4,01%
Revenue (1Y)5,42%
Earnings (1Y)4,87%
FCF Growth (3Y)8,00%
Kwaliteit
Return on Equity
15,28%
ROIC9,12%
Net Margin10,40%
Op. Margin13,53%
Veiligheid
Debt / Equity
0,57
Current Ratio1,62
Interest Coverage9,69
Waardering
P/E Ratio
20,74
P/B Ratio3,05
EV/EBITDA18,15
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 5,42% | Revenue Growth (3Y) | 4,07% |
| Earnings Growth (1Y) | 4,87% | Earnings Growth (3Y) | 17,50% |
| Revenue Growth (5Y) | 4,01% | Earnings Growth (5Y) | 12,63% |
| Profitability | |||
| Revenue (TTM) | 3,78B | Net Income (TTM) | 392,79M |
| ROE | 15,28% | ROA | 7,48% |
| Gross Margin | 29,58% | Operating Margin | 13,53% |
| Net Margin | 10,40% | Free Cash Flow (TTM) | 299,58M |
| ROIC | 9,12% | FCF Growth (3Y) | 8,00% |
| Safety | |||
| Debt / Equity | 0,57 | Current Ratio | 1,62 |
| Interest Coverage | 9,69 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 20,74 | P/B Ratio | 3,05 |
| P/S Ratio | 2,16 | PEG Ratio | 3,60 |
| EV/EBITDA | 18,15 | Dividend Yield | 0,02% |
| Market Cap | 8,15B | Enterprise Value | 9,27B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3,78B | 3,58B | 3,49B | 3,32B | 3,23B |
| Net Income | 392,79M | 374,54M | 284,49M | 239,29M | 244,10M |
| EPS (Diluted) | 5,89 | 5,53 | 4,25 | 3,59 | 3,60 |
| Gross Profit | 1,12B | 1,36B | 1,26B | 1,16B | 1,16B |
| Operating Income | 510,88M | 496,50M | 404,02M | 379,27M | 347,35M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 5,25B | 4,43B | 4,45B | 4,20B | 4,14B |
| Total Liabilities | 2,54B | 1,95B | 2,13B | 2,14B | 2,16B |
| Shareholders' Equity | 2,67B | 2,47B | 2,31B | 2,05B | 1,97B |
| Total Debt | 1,53B | 1,08B | 1,18B | 1,22B | 1,24B |
| Cash & Equivalents | 402,42M | 223,84M | 223,64M | 141,73M | 122,93M |
| Current Assets | 1,89B | 1,48B | 1,55B | 1,43B | 1,36B |
| Current Liabilities | 1,17B | 1,07B | 1,25B | 917,18M | 982,49M |